Pages that link to "Q22241916"
Jump to navigation
Jump to search
The following pages link to Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association (Q22241916):
Displayed 50 items.
- Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker? (Q22241777) (← links)
- Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association (Q22241921) (← links)
- Effect of exercise on 24-month weight loss maintenance in overweight women (Q24634744) (← links)
- Diabetes Care in Republic of Macedonia: Challenges and Opportunities (Q26750826) (← links)
- Cardiovascular Outcome Studies in Diabetes: How Do We Make Sense of These New Data? (Q26752255) (← links)
- Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses (Q26766025) (← links)
- Renal Denervation: A Potential Novel Treatment for Type 2 Diabetes Mellitus? (Q26778196) (← links)
- The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis (Q26795473) (← links)
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association (Q26798326) (← links)
- Aspirin resistance: current status and role of tailored therapy (Q26851367) (← links)
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. (Q27687851) (← links)
- Dietary marine-derived long-chain monounsaturated fatty acids and cardiovascular disease risk: a mini review (Q28073481) (← links)
- Approaches to prevention of cardiovascular complications and events in diabetes mellitus (Q28209964) (← links)
- Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity (Q28578061) (← links)
- Heart disease and stroke statistics--2014 update: a report from the American Heart Association (Q29547691) (← links)
- The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: II. Therapeutic management of atherogenic dyslipidemia. (Q30380628) (← links)
- Cardiovascular risk factor management of myocardial infarction patients with and without diabetes in the Netherlands between 2002 and 2006: a cross-sectional analysis of baseline data (Q30530802) (← links)
- The adverse association of diabetes with risk of first acute myocardial infarction is modified by physical activity and body mass index: prospective data from the HUNT Study, Norway. (Q30858405) (← links)
- Cardiovascular safety of empagliflozin in patients with type 2 diabetes: a meta-analysis of data from randomized placebo-controlled trials (Q31112303) (← links)
- Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment (Q33165286) (← links)
- Prevalence of prehypertension and associated cardiovascular risk profiles among prediabetic Omani adults (Q33327175) (← links)
- Diabetes mellitus and mortality after acute coronary syndrome as a first or recurrent cardiovascular event (Q33378481) (← links)
- Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials (Q33515541) (← links)
- Documentation of body mass index and control of associated risk factors in a large primary care network (Q33518929) (← links)
- Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes study (Q33602214) (← links)
- Hypertension and diabetes: should we treat early surrogates? What are the cons? (Q33610656) (← links)
- Should all diabetic patients be treated with a statin? (Q33610801) (← links)
- Is Diabetes Mellitus a Risk Factor for Poor Outcomes after Left Ventricular Assist Device Placement? (Q33613375) (← links)
- Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes (Q33652884) (← links)
- Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries. The MASS IV-DM Trial (Q33709966) (← links)
- Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats. (Q33714897) (← links)
- A retrospective cohort study on the risk of stroke in relation to a priori health knowledge level among people with type 2 diabetes mellitus in Taiwan (Q33716777) (← links)
- Physical activity and reported barriers to activity among type 2 diabetic patients in the United arab emirates (Q33718105) (← links)
- Nutrition, environment and cardiovascular health (NESCAV): protocol of an inter-regional cross-sectional study (Q33747018) (← links)
- Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data (Q33753663) (← links)
- New frontiers in the treatment of diabetic dyslipidemia (Q33776236) (← links)
- Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone (Q33853527) (← links)
- Prognostic value of coronary computed tomographic angiography in diabetic patients without known coronary artery disease (Q33873193) (← links)
- The impact of weight gain on motivation, compliance, and metabolic control in patients with type 2 diabetes mellitus (Q33888236) (← links)
- Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications (Q33901576) (← links)
- The Chronic CARe for diAbeTes study (CARAT): a cluster randomized controlled trial (Q33986499) (← links)
- Hyperlipidemia medication management in patients admitted for a myocardial infarction (Q34045514) (← links)
- American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary (Q34081331) (← links)
- Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors (Q34133889) (← links)
- Are Cardiovascular Benefits in Statin Lipid Effects Dependent on Baseline Lipid Levels? (Q34151632) (← links)
- Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study (Q34158078) (← links)
- Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade (Q34203622) (← links)
- Combination therapy of statins and fibrates in the management of cardiovascular risk (Q34305993) (← links)
- Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the Translating Research into Action for Diabetes (TRIAD) study. (Q34331209) (← links)
- Dietary fiber, carbohydrate quality and quantity, and mortality risk of individuals with diabetes mellitus (Q34395592) (← links)